Here’s why a COVID-19 vaccine could end up costing you a small fortune

Los Angeles Times

21 April 2020 - Things have gone from bad to worse for Brian Helstien. For a decade, he’s been grappling with multiple myeloma, a form of blood cancer. Now he needs surgery for a leaky heart valve.

But because his medical network, Kaiser Permanente, like all healthcare providers, is dealing with a tsunami of COVID-19 patients, the Laguna Woods resident has been informed his non-life-threatening ticker trouble is an “elective” procedure.

“They said maybe they’ll be able to get to me in three to six months,” Helstien, 71, told me. “As if we were talking about a nose job instead of heart surgery.”

Read Los Angeles Times article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Vaccine , Affordability , COVID-19